| Dr Yunfei Wei, MD | |
|
11480 Brookshire Ave, Suite 309, Downey, CA 90241-5018 | |
| (562) 869-1201 | |
| (562) 869-1201 |
| Full Name | Dr Yunfei Wei |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 36 Years |
| Location | 11480 Brookshire Ave, Downey, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801075684 | NPI | - | NPPES |
| A99930 | Other | CA | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | A99930 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ahmc Anaheim Regional Medical Center | Anaheim, CA | Hospital |
| St Jude Medical Center | Fullerton, CA | Hospital |
| West Anaheim Medical Center | Anaheim, CA | Hospital |
| Placentia Linda Hospital | Placentia, CA | Hospital |
| La Palma Intercommunity Hospital | La palma, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pacific Cancer Medical Center Inc | 4486547502 | 5 |
| Los Angeles Hematology-oncology Medical Group | 6608819594 | 23 |
News Archive
Enobia Pharma today announced positive results for its Phase II juvenile clinical trial of ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy intended for the treatment of hypophosphatasia (HPP). Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.
University of Granada scientists have patented a new treatment for acne that is based on completely natural substances and is much more effective than artificial formulas because it does not create resistance to bacteria and has no secondary effects.
Genta Incorporated today announced financial results for the quarter ended March 31, 2010.
In what are believed to be the first studies of their kind, Cedars-Sinai researchers recording the real-time firing of individual nerve cells in the brain found that a specific type of neuron in a structure called the amygdala performed differently in people who suffer from autism spectrum disorder than in those who do not.
The National Human Genome Research Institute (NHGRI) and the National Cancer Institute (NCI), parts of the National Institutes of Health (NIH), have teamed with Group Health Cooperative in Seattle and Henry Ford Health System in Detroit to launch a study to investigate the interest level of healthy, young adults in receiving genetic testing for eight common conditions.
› Verified 1 days ago
| Entity Name | County Of Los Angeles |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851363188 PECOS PAC ID: 1850296534 Enrollment ID: O20031204001218 |
News Archive
Enobia Pharma today announced positive results for its Phase II juvenile clinical trial of ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy intended for the treatment of hypophosphatasia (HPP). Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.
University of Granada scientists have patented a new treatment for acne that is based on completely natural substances and is much more effective than artificial formulas because it does not create resistance to bacteria and has no secondary effects.
Genta Incorporated today announced financial results for the quarter ended March 31, 2010.
In what are believed to be the first studies of their kind, Cedars-Sinai researchers recording the real-time firing of individual nerve cells in the brain found that a specific type of neuron in a structure called the amygdala performed differently in people who suffer from autism spectrum disorder than in those who do not.
The National Human Genome Research Institute (NHGRI) and the National Cancer Institute (NCI), parts of the National Institutes of Health (NIH), have teamed with Group Health Cooperative in Seattle and Henry Ford Health System in Detroit to launch a study to investigate the interest level of healthy, young adults in receiving genetic testing for eight common conditions.
› Verified 1 days ago
| Entity Name | Pacific Cancer Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336113489 PECOS PAC ID: 4486547502 Enrollment ID: O20040203001045 |
News Archive
Enobia Pharma today announced positive results for its Phase II juvenile clinical trial of ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy intended for the treatment of hypophosphatasia (HPP). Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.
University of Granada scientists have patented a new treatment for acne that is based on completely natural substances and is much more effective than artificial formulas because it does not create resistance to bacteria and has no secondary effects.
Genta Incorporated today announced financial results for the quarter ended March 31, 2010.
In what are believed to be the first studies of their kind, Cedars-Sinai researchers recording the real-time firing of individual nerve cells in the brain found that a specific type of neuron in a structure called the amygdala performed differently in people who suffer from autism spectrum disorder than in those who do not.
The National Human Genome Research Institute (NHGRI) and the National Cancer Institute (NCI), parts of the National Institutes of Health (NIH), have teamed with Group Health Cooperative in Seattle and Henry Ford Health System in Detroit to launch a study to investigate the interest level of healthy, young adults in receiving genetic testing for eight common conditions.
› Verified 1 days ago
| Entity Name | Los Angeles Hematology-oncology Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457409674 PECOS PAC ID: 6608819594 Enrollment ID: O20050601001068 |
News Archive
Enobia Pharma today announced positive results for its Phase II juvenile clinical trial of ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy intended for the treatment of hypophosphatasia (HPP). Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.
University of Granada scientists have patented a new treatment for acne that is based on completely natural substances and is much more effective than artificial formulas because it does not create resistance to bacteria and has no secondary effects.
Genta Incorporated today announced financial results for the quarter ended March 31, 2010.
In what are believed to be the first studies of their kind, Cedars-Sinai researchers recording the real-time firing of individual nerve cells in the brain found that a specific type of neuron in a structure called the amygdala performed differently in people who suffer from autism spectrum disorder than in those who do not.
The National Human Genome Research Institute (NHGRI) and the National Cancer Institute (NCI), parts of the National Institutes of Health (NIH), have teamed with Group Health Cooperative in Seattle and Henry Ford Health System in Detroit to launch a study to investigate the interest level of healthy, young adults in receiving genetic testing for eight common conditions.
› Verified 1 days ago
| Entity Name | Valley Tumor Medical Group A Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366584948 PECOS PAC ID: 8820045966 Enrollment ID: O20050725001250 |
News Archive
Enobia Pharma today announced positive results for its Phase II juvenile clinical trial of ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy intended for the treatment of hypophosphatasia (HPP). Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.
University of Granada scientists have patented a new treatment for acne that is based on completely natural substances and is much more effective than artificial formulas because it does not create resistance to bacteria and has no secondary effects.
Genta Incorporated today announced financial results for the quarter ended March 31, 2010.
In what are believed to be the first studies of their kind, Cedars-Sinai researchers recording the real-time firing of individual nerve cells in the brain found that a specific type of neuron in a structure called the amygdala performed differently in people who suffer from autism spectrum disorder than in those who do not.
The National Human Genome Research Institute (NHGRI) and the National Cancer Institute (NCI), parts of the National Institutes of Health (NIH), have teamed with Group Health Cooperative in Seattle and Henry Ford Health System in Detroit to launch a study to investigate the interest level of healthy, young adults in receiving genetic testing for eight common conditions.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yunfei Wei, MD 18000 Studebaker Rd Ste 800, Cerritos, CA 90703-2671 Ph: (562) 735-3226 | Dr Yunfei Wei, MD 11480 Brookshire Ave, Suite 309, Downey, CA 90241-5018 Ph: (562) 869-1201 |
News Archive
Enobia Pharma today announced positive results for its Phase II juvenile clinical trial of ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy intended for the treatment of hypophosphatasia (HPP). Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.
University of Granada scientists have patented a new treatment for acne that is based on completely natural substances and is much more effective than artificial formulas because it does not create resistance to bacteria and has no secondary effects.
Genta Incorporated today announced financial results for the quarter ended March 31, 2010.
In what are believed to be the first studies of their kind, Cedars-Sinai researchers recording the real-time firing of individual nerve cells in the brain found that a specific type of neuron in a structure called the amygdala performed differently in people who suffer from autism spectrum disorder than in those who do not.
The National Human Genome Research Institute (NHGRI) and the National Cancer Institute (NCI), parts of the National Institutes of Health (NIH), have teamed with Group Health Cooperative in Seattle and Henry Ford Health System in Detroit to launch a study to investigate the interest level of healthy, young adults in receiving genetic testing for eight common conditions.
› Verified 1 days ago
Brandon Lui, Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 9333 Imperial Hwy, Downey, CA 90242 Phone: 562-657-9000 | |
Mr. Nazar Al-bussam, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 11411 Brookshire Ave, Ste 503, Downey, CA 90241 Phone: 562-861-8853 Fax: 562-861-8820 | |
Betzabe M Alday, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 7601 Imperial Hwy, Downey, CA 90242 Phone: 562-803-0124 Fax: 562-803-5569 | |
Dr. Kiran Pandey, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 9333 Imperial Hwy, Downey, Downey, CA 90242 Phone: 877-608-0044 | |
Sohail Afra, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 9449 Imperial Hwy # C-228, Downey, CA 90242 Phone: 562-657-4958 | |
Ava Azimi, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 11500 Brookshire Ave, Downey, CA 90241 Phone: 562-904-5000 | |
Bhavik V Thakkar, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 11525 Brookshire Ave, Suite 400, Downey, CA 90241 Phone: 562-869-4497 Fax: 562-869-6317 |